Press "Enter" to skip to content

New patent for Biogen Idec drug SPINRAZA

0
Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for SPINRAZA
Annual Drug Patent Expirations for SPINRAZA

Spinraza is a drug marketed by Biogen Idec and is included in one NDA. It is available from one supplier. There are eight patents protecting this drug.

This drug has seventy-nine patent family members in twenty-seven countries.

The generic ingredient in SPINRAZA is nusinersen sodium. One supplier is listed for this compound. Additional details are available on the nusinersen sodium profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at

    Leave a Reply

    DrugPatentWatch - Make Better Decisions